Dr. Mauskar and Dr. Reutter had no relevant financial conflicts of interest.
Clinical Topics
-
Despite benefits, extended-interval pembro uptake remains low -
Time to cancer diagnoses in U.S. averages 5 months -
BRAF/MEK combo shows long-term efficacy in melanoma -
-
Digital Edition
Conference Coverage
-
-
Cannabis in Cancer: What Oncologists and Patients Should Know -
Changes in Age-Related Mortality in Malignant Melanoma From 1999- 2022: A CDC Wonder Study -
Geographical Trends in Malignant Melanoma from 1999-2022: A CDC Wonder Study -
-
One Patient Changed This Oncologist’s View of Hope. Here’s How. -
Study Highlights Melanoma Survival Disparities in Rural vs Urban Settings -
Neoadjuvant Checkpoint Inhibition Study Sets New Standard of Care in Melanoma -
New mRNA Vaccines in Development for Cancer and Infections -
No Routine Cancer Screening Option? New MCED Tests May Help
Question 1 of 5
